Re: Peptide manufacturing capacity Roche and LLY are playing hardball by siding with the FTC in an effort to block NVO from increasing its Wegovy manufacturing capacity by acquiring CTLT: https://www.reuters.com/business/healthcare-pharmaceuticals/roche-comes-out-against-clearing-takeover-drug-manufacturer-catalent-2024-10-23/ Big Pharma don't ordinarily oppose acquisitions by other Big Pharma, but the obesity market calls for unconventional maneuvers, evidently.